- Positive externality
- A positive externality is a benefit that spills over from an exchange to a third party, who enjoys it without paying for it.
- Negative externality
- A negative externality is a cost that an exchange between a buyer and a seller imposes on a third party who is not part of the exchange.
Private, external and social benefit
Can you name the three kinds of benefit on an externality diagram?
On the diagram, private and social benefit are curves, and external benefit is the gap between them.
Private benefits are the part of the benefit of a good that goes to the buyer or the seller themselves.
Can you think of an example?
A flu jab protects the person vaccinated. That protection is why they pay for it, so demand, the marginal private benefit (MPB) curve, already counts it.
External benefits are the benefits of a good that go to third parties, who do not pay for them; per unit, they are the gap between MSB and MPB.
Can you think of an example?
A beekeeper's bees pollinate the apple trees in the orchard next door, so the orchard grows more fruit. The orchard owner pays the beekeeper nothing for it, so the honey price never counts it.
Social benefits are all the benefits of a good to society: the private benefits to the buyer plus the value of all its positive externalities.
Can you think of an example?
Education raises the earnings of the person educated, a private benefit. The economist Walter McMahon finds that a well-educated population also brings better health and lower crime, an external benefit. Social benefit is the two together.
The marketBuyers pay for their own protection only, so demand is MPB. It meets supply, MPC, at P1 and Q1.
Adding the external benefit puts MSB above MPB, so the optimum sits up at P2 and Q2, beyond the market's P1 and Q1.
- Demand for flu jabs is MPB. With no spillover costs in producing them, supply is the marginal private cost (MPC), and the market settles at P1 and Q1, where MPB equals MPC.
- Adding the external benefit of each jab to MPB gives the marginal social benefit (MSB) curve, which lies above MPB.
- MSB meets MPC at Q2, to the right of Q1. P2 is the price on the supply curve if the market produced Q2. The market does not count the external benefit, so flu jabs are under-produced and under-consumed.
Check yourself
This diagram shows the market for flu jabs. Name the three curves.
Curve A: MPC. A slopes upward: it is supply, the marginal private cost of each jab. With no spillover costs in making jabs, it is also MSC.
Curve B: MPB. B is the lower of the two downward-sloping curves: demand, which counts only the benefit to the person who is vaccinated.
Curve C: MSB. C lies above demand by the benefit each jab gives other people, so it is marginal social benefit, MPB plus the external benefit.
The optimumCounting the benefit to others, society wants Q2, where MSB meets MPC, at P2.
Left alone, the market stops short of the optimum, to the left at Q1 instead of Q2, with the price at P1 instead of P2.
- Between Q1 and Q2, MSB lies above MPC: each of those jabs is worth more to society than it costs to make, yet no buyer pays for the share of the benefit that goes to other people.
- The gain the market misses is the welfare loss: the triangle between MSB and MPC from Q1 to Q2, pointing at the optimum. A subsidy per jab equal to MSB minus MPB would carry the market to Q2.
Check yourself
Why does a free market provide fewer flu jabs than the social optimum?
Isn't the positive externality of a flu jab that it stops me catching flu?
No. Your own protection is the private benefit, and demand already counts it. The externality is the protection your jab gives other people, who are less likely to catch flu from you and pay nothing for it. If you name the buyer's own gain as the externality, the MSB curve has nothing to add.
Draw MSB above MPB, with one supply curve for MPC = MSC. Mark Q1 where MPB meets MPC as the market output and Q2 where MSB meets MPC as the optimum, then shade the welfare loss between MSB and MPC from Q1 to Q2. Name the third party and say what they gain.
Check yourself
Three of these create a positive externality. Which one does not?
Exam question
Using a diagram, explain why a free market is likely to under-provide flu vaccinations. [4]
Buyers pay according to their private benefit, so demand is MPB and the market settles where MPB meets MPC at Q1. Vaccination also protects people who were not vaccinated, an external benefit, so MSB lies above MPB and meets MPC at a larger optimum quantity Q2. Between Q1 and Q2 each jab's social benefit exceeds its cost, so the market under-provides and there is a welfare loss between MSB and MPC.
One mark each for: demand shows only MPB; the external benefit to others, named; MSB above MPB giving an optimum Q2 above Q1; the welfare loss shown between MSB and MPC. Naming the vaccinated person's own protection as the externality loses the second mark.
Buyers count only their private benefit, so demand shows MPB and the market settles at Q1, where MPB meets MPC. Adding the external benefit gives MSB above MPB, and the optimum Q2 lies to the right. The market under-produces, leaving a welfare loss between Q1 and Q2.